vs

Side-by-side financial comparison of Direct Digital Holdings, Inc. (DRCT) and Tonix Pharmaceuticals Holding Corp. (TNXP). Click either name above to swap in a different company.

Direct Digital Holdings, Inc. is the larger business by last-quarter revenue ($8.4M vs $5.4M, roughly 1.6× Tonix Pharmaceuticals Holding Corp.). Direct Digital Holdings, Inc. runs the higher net margin — -138.7% vs -870.3%, a 731.6% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs -7.4%). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs -38.6%).

Devolver Digital, Inc. is an American video game publisher based in Austin, Texas, specializing in the publishing of indie games. The company was founded in June 2009 by Nigel Lowrie, Harry Miller, Graeme Struthers, Rick Stults, and Mike Wilson, five executives who had been involved with Gathering of Developers and Gamecock Media Group, which published games on developer-friendly terms, but due to the high cost associated with releasing retail games saw themselves acquired and dissolved by la...

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

DRCT vs TNXP — Head-to-Head

Bigger by revenue
DRCT
DRCT
1.6× larger
DRCT
$8.4M
$5.4M
TNXP
Growing faster (revenue YoY)
TNXP
TNXP
+116.2% gap
TNXP
108.8%
-7.4%
DRCT
Higher net margin
DRCT
DRCT
731.6% more per $
DRCT
-138.7%
-870.3%
TNXP
Faster 2-yr revenue CAGR
TNXP
TNXP
Annualised
TNXP
47.4%
-38.6%
DRCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DRCT
DRCT
TNXP
TNXP
Revenue
$8.4M
$5.4M
Net Profit
$-11.7M
$-46.9M
Gross Margin
26.8%
80.4%
Operating Margin
-53.4%
-895.8%
Net Margin
-138.7%
-870.3%
Revenue YoY
-7.4%
108.8%
Net Profit YoY
-434.7%
-112.2%
EPS (diluted)
$-74.97
$-4.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DRCT
DRCT
TNXP
TNXP
Q4 25
$8.4M
$5.4M
Q3 25
$8.0M
$3.3M
Q2 25
$10.1M
$2.0M
Q1 25
$8.2M
$2.4M
Q4 24
$9.1M
$2.6M
Q3 24
$9.1M
$2.8M
Q2 24
$21.9M
$2.2M
Q1 24
$22.3M
$2.5M
Net Profit
DRCT
DRCT
TNXP
TNXP
Q4 25
$-11.7M
$-46.9M
Q3 25
$-2.7M
$-32.0M
Q2 25
$-2.2M
$-28.3M
Q1 25
$-2.4M
$-16.8M
Q4 24
$-2.2M
$-22.1M
Q3 24
$-2.7M
$-14.2M
Q2 24
$-590.0K
$-78.8M
Q1 24
$-775.0K
$-14.9M
Gross Margin
DRCT
DRCT
TNXP
TNXP
Q4 25
26.8%
80.4%
Q3 25
27.7%
58.4%
Q2 25
35.1%
-63.8%
Q1 25
29.3%
61.2%
Q4 24
32.5%
54.2%
Q3 24
38.7%
44.9%
Q2 24
27.1%
-52.5%
Q1 24
22.4%
33.1%
Operating Margin
DRCT
DRCT
TNXP
TNXP
Q4 25
-53.4%
-895.8%
Q3 25
-49.0%
-1005.1%
Q2 25
-23.9%
-1416.2%
Q1 25
-48.1%
-660.9%
Q4 24
-51.8%
-870.6%
Q3 24
-40.3%
-551.2%
Q2 24
-9.4%
-3501.6%
Q1 24
-12.6%
-860.2%
Net Margin
DRCT
DRCT
TNXP
TNXP
Q4 25
-138.7%
-870.3%
Q3 25
-33.6%
-972.9%
Q2 25
-22.2%
-1415.0%
Q1 25
-28.9%
-692.8%
Q4 24
-24.0%
-856.2%
Q3 24
-29.6%
-503.6%
Q2 24
-2.7%
-3567.8%
Q1 24
-3.5%
-601.9%
EPS (diluted)
DRCT
DRCT
TNXP
TNXP
Q4 25
$-74.97
$-4.28
Q3 25
$-0.24
$-3.59
Q2 25
$-0.23
$-3.86
Q1 25
$-0.35
$-2.84
Q4 24
$-90.17
$2302.65
Q3 24
$-0.71
$-22.68
Q2 24
$-0.16
$-1920.85
Q1 24
$-0.22
$-535.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DRCT
DRCT
TNXP
TNXP
Cash + ST InvestmentsLiquidity on hand
$728.0K
$207.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-7.0M
$245.2M
Total Assets
$20.2M
$277.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DRCT
DRCT
TNXP
TNXP
Q4 25
$728.0K
$207.6M
Q3 25
$871.0K
$190.1M
Q2 25
$1.6M
$125.3M
Q1 25
$1.8M
$131.7M
Q4 24
$1.4M
$98.8M
Q3 24
$4.1M
$28.2M
Q2 24
$1.1M
$4.2M
Q1 24
$3.3M
$7.0M
Total Debt
DRCT
DRCT
TNXP
TNXP
Q4 25
Q3 25
$10.8M
Q2 25
$33.5M
Q1 25
$32.9M
Q4 24
$8.7M
Q3 24
$150.0K
$9.4M
Q2 24
$34.8M
$10.1M
Q1 24
$32.4M
$10.8M
Stockholders' Equity
DRCT
DRCT
TNXP
TNXP
Q4 25
$-7.0M
$245.2M
Q3 25
$-6.7M
$231.1M
Q2 25
$-24.6M
$168.0M
Q1 25
$-23.3M
$180.4M
Q4 24
$-19.7M
$139.6M
Q3 24
$-16.7M
$74.2M
Q2 24
$-10.5M
$42.1M
Q1 24
$-7.5M
$108.1M
Total Assets
DRCT
DRCT
TNXP
TNXP
Q4 25
$20.2M
$277.2M
Q3 25
$22.5M
$252.4M
Q2 25
$23.3M
$187.4M
Q1 25
$23.8M
$192.9M
Q4 24
$26.0M
$162.9M
Q3 24
$31.3M
$95.0M
Q2 24
$48.5M
$70.3M
Q1 24
$52.8M
$135.3M
Debt / Equity
DRCT
DRCT
TNXP
TNXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.06×
Q3 24
0.13×
Q2 24
0.24×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DRCT
DRCT
TNXP
TNXP
Operating Cash FlowLast quarter
$-1.9M
$-39.6M
Free Cash FlowOCF − Capex
$-41.5M
FCF MarginFCF / Revenue
-770.4%
Capex IntensityCapex / Revenue
34.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-103.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DRCT
DRCT
TNXP
TNXP
Q4 25
$-1.9M
$-39.6M
Q3 25
$-1.6M
$-28.8M
Q2 25
$-2.7M
$-14.8M
Q1 25
$-2.7M
$-16.6M
Q4 24
$-1.6M
$-14.6M
Q3 24
$3.0M
$-18.8M
Q2 24
$-4.4M
$-9.9M
Q1 24
$-5.7M
$-17.6M
Free Cash Flow
DRCT
DRCT
TNXP
TNXP
Q4 25
$-41.5M
Q3 25
$-29.7M
Q2 25
$-15.4M
Q1 25
$-16.6M
Q4 24
$-14.6M
Q3 24
$-18.8M
Q2 24
Q1 24
$-17.7M
FCF Margin
DRCT
DRCT
TNXP
TNXP
Q4 25
-770.4%
Q3 25
-904.1%
Q2 25
-768.8%
Q1 25
-682.8%
Q4 24
-566.7%
Q3 24
-666.5%
Q2 24
Q1 24
-712.4%
Capex Intensity
DRCT
DRCT
TNXP
TNXP
Q4 25
34.8%
Q3 25
29.2%
Q2 25
26.4%
Q1 25
0.2%
Q4 24
0.1%
Q3 24
0.3%
Q2 24
0.0%
Q1 24
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DRCT
DRCT

Buy Side Advertising$8.2M98%
Other$183.0K2%

TNXP
TNXP

Zembrace Symtouch$3.1M58%
Other$2.3M42%

Related Comparisons